NCT06273124View on ClinicalTrials.gov

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

December 11, 2024

Study Completion Date

December 11, 2024

Conditions
Type1diabetes
Interventions
DEVICE

SteadiSet Extended Wear Infusion Set

Each participant will be given 12 Extended Wear Infusion Sets to wear over 12 wear periods up to 168 hours each.

Trial Locations (15)

10029

Icahn School of Medicine at Mt. Sinai, New York

13210

SUNY Upstate Medical University, Syracuse

30076

Endocrine Research Solutions, Roswell

48202

Henry Ford Health System, Detroit

55416

International Diabetes Center - HealthPartners Institute, Minneapolis

55905

Mayo Clinic, Rochester

60208

Northwestern University, Evanston

78731

Texas Diabetes and Endocrinology, Austin

80045

Barbara Davis Center, Aurora

83404

Rocky Mountain Clinical Research, Idaho Falls

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

94305

Stanford University, Stanford

98057

Rainier Clinical Research Center, Renton

98109

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Tandem Diabetes Care, Inc.

INDUSTRY